Skip to Content

Saratoga Health & Biotechnology A SHPAX

Medalist Rating as of | See Saratoga Investment Hub
  • NAV / 1-Day Return 18.88  /  0.11 %
  • Total Assets 11.5 Mil
  • Adj. Expense Ratio
    2.900%
  • Expense Ratio 2.900%
  • Distribution Fee Level High
  • Share Class Type Front Load
  • Category Health
  • Investment Style Large Blend
  • Min. Initial Investment 250
  • Status Open
  • TTM Yield
  • Turnover 23%

Morningstar’s Analysis SHPAX

Will SHPAX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Saratoga Health& Biotechnology A's Average People Pillar and Process Pillar ratings are n't enough to prevent other weaknesses from sending this strategy to a Morningstar Medalist Rating of Negative.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the most expensive quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings SHPAX

  • Current Portfolio Date
  • Equity Holdings 31
  • Bond Holdings 0
  • Other Holdings 2
  • % Assets in Top 10 Holdings 39.4
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector
4.69
558,448
Healthcare
4.48
534,175
Healthcare
4.18
498,088
Healthcare
3.88
462,760
Healthcare
3.87
461,297
Healthcare
3.82
454,514
Healthcare
3.73
443,948
Healthcare
3.63
432,527
Healthcare
3.58
426,439
Healthcare
3.54
422,213
Healthcare